Veracyte expects to double revenue with new offerings, says CEO 14-Jan-2016 By Melissa Fassbender With three commercialized products and a new San Francisco-based facility, Veracyte’s CEO says company could double revenue in a few years.
update NHS rejects suggestion a lack of guidance has slowed biosimilar uptake 06-Oct-2015 By Gareth Macdonald The NHS has rejected Napp Pharmaceuticals’ accusation it lacks biosimilar guidance, citing a recently published policy document.
Update - Wholesale cost of Zarxio will be 15% less than Amgen's Neupogen Biosimilars land in the US as Sandoz launches Zarxio 03-Sep-2015 By Dan Stanton Sandoz has launched Zarxio, the first biosimilar in the US, despite a last ditch effort to block the copycat version of Neupogen by Amgen.
NJ Assembly committee approves biosimilar substitution bill 12-May-2015 By Zachary Brennan Under the bill first proposed in 2014, which won unanimous approval last week from a New Jersey Assembly committee, pharmacists would have to notify prescribers within five days of dispensing an interchangeable biosimilar.
Tekmira Ebola RNA drug starts Phase II 13-Mar-2015 By Fiona BARRY A clinical trial of Tekmira’s non-vaccine Ebola therapy began on Wednesday in Sierra Leone.
Unilife creates world's first multi-chamber syringe with in-built safety device Unilife creates world's first multi-chamber syringe with in-built safety device 24-Aug-2011 By Natalie Morrison Unilife has developed the world’s first multi-chamber prefilled syringes that have an in-built safety mechanism.
